Sign Up to like & get
recommendations!
1
Published in 2017 at "Diabetologia"
DOI: 10.1007/s00125-017-4301-8
Abstract: Aims/hypothesisSodium-glucose co-transporter-2 inhibitors (SGLT2i) are indicated for the treatment of type 2 diabetes and may also improve glucose control in type 1 diabetes. In 2015, regulatory agencies warned that SGLT2i may favour diabetic ketoacidosis (DKA).…
read more here.
Keywords:
dka;
reporting;
dka reports;
reports sglt2i ... See more keywords